D. Boturyn, J. L. Coll, E. Garanger, M. C. Favrot, and P. Dumy, Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis, J. Am. Chem. Soc, vol.126, pp.5730-5739, 2004.

J. Ciccione, T. Jia, J. L. Coll, K. Parra, M. Amblard et al., Unambiguous and controlled one-pot synthesis of multifunctional silica nanoparticles, Chem. Mater, vol.28, pp.885-889, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01275703

T. Curk, J. Dobnikar, and D. Frenkel, Optimal multivalent targeting of membranes with many distinct receptors, Proc. Natl. Acad. Sci. U.S.A, vol.114, pp.7210-7215, 2017.

D. Duret, A. Grassin, M. Henry, T. Jacquet, F. Thoreau et al., Polymultivalent" polymer-peptide cluster conjugates for an enhanced targeting of cells expressing alphavbeta3 integrins, Bioconjug. Chem, vol.28, pp.2241-2245, 2017.

A. Eldar-boock, R. Blau, C. Ryppa, H. Baabur-cohen, A. Many et al., Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study, J. Drug Target, vol.25, pp.829-844, 2017.

A. C. Faure, S. Dufort, V. Josserand, P. Perriat, J. L. Coll et al., Control of the in vivo biodistribution of hybrid nanoparticles with different poly (ethylene glycol) coatings, Small, vol.5, pp.2565-2575, 2009.

E. Garanger, D. Boturyn, Z. Jin, P. Dumy, M. C. Favrot et al., New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors, Mol. Ther, vol.12, pp.1168-1175, 2005.

J. A. Getz, O. Cheneval, D. J. Craik, and P. S. Daugherty, Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration, ACS Chem. Biol, vol.8, pp.1147-1154, 2013.

Q. He, J. Zhang, J. Shi, Z. Zhu, L. Zhang et al., The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses, Biomaterials, vol.31, pp.1085-1092, 2010.

S. Hirsjarvi, S. Dufort, J. Gravier, I. Texier, Q. Yan et al., Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models, Nanomedicine, vol.9, pp.375-387, 2013.

T. Ishida, S. Kashima, and H. Kiwada, The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats, J. Control. Release, vol.126, pp.162-165, 2008.

T. Jia, J. Choi, J. Ciccione, M. Henry, A. Mehdi et al., Heteromultivalent targeting of integrin alphavbeta3 and neuropilin 1 promotes cell survival via the activation of the IGF-1/insulin receptors, Biomaterials, vol.155, pp.64-79, 2018.

Y. J. Kim, K. Jung, D. S. Baek, S. S. Hong, and Y. S. Kim, Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin beta1-driven Src-Akt bypass signaling, Oncogene, vol.36, pp.2543-2552, 2017.

M. H. Li, S. K. Choi, P. R. Leroueil, and J. R. Baker, Evaluating binding avidities of populations of heterogeneous multivalent ligand-functionalized nanoparticles, ACS Nano, vol.8, pp.5600-5609, 2014.

W. Q. Liu, Y. Lepelletier, M. Montes, L. Borriello, R. Jarray et al., NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model, Cancer Lett, vol.414, pp.88-98, 2018.

M. Los, S. Maddika, B. Erb, and K. Schulze-osthoff, Switching Akt: from survival signaling to deadly response, BioEssays, vol.31, pp.492-495, 2009.

S. Miyamoto, S. K. Akiyama, and K. M. Yamada, Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function, Science, vol.267, pp.883-885, 1995.

M. Nieberler, U. Reuning, F. Reichart, J. Notni, H. J. Wester et al., Exploring the Role of RGD-Recognizing Integrins in Cancer, Cancers, vol.9, 2017.

A. Novoa, N. Pellegrini-moise, D. Bechet, M. Barberi-heyob, and Y. Chapleur, Sugarbased peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1, Bioorg. Med. Chem, vol.18, pp.3285-3298, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00476266

H. Otsuka, Y. Nagasaki, and K. Kataoka, PEGylated nanoparticles for biological and pharmaceutical applications, Adv. Drug Deliv. Rev, vol.55, pp.403-419, 2003.

G. Y. Perret, A. Starzec, N. Hauet, J. Vergote, M. Le-pecheur et al., In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1, Nucl. Med. Biol, vol.31, pp.575-581, 2004.

C. Rangger, A. Helbok, E. Von-guggenberg, J. Sosabowski, T. Radolf et al., Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles, Int. J. Nanomed, vol.7, pp.5889-5900, 2012.

L. Sancey, E. Garanger, S. Foillard, G. Schoen, A. Hurbin et al., Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide, Mol. Ther, vol.17, pp.837-843, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00369024

C. S. Schneider, Q. Xu, N. J. Boylan, J. Chisholm, B. C. Tang et al., Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation, 2017.

G. Su, H. Jiang, B. Xu, Y. Yu, and X. Chen, Effects of protein corona on active and passive targeting of cyclic RGD peptide-functionalized PEGylation nanoparticles, Mol. Pharm, vol.15, pp.5019-5030, 2018.

J. S. Suk, Q. Xu, N. Kim, J. Hanes, and L. M. Ensign, PEGylation as a strategy for improving nanoparticle-based drug and gene delivery, Adv. Drug Deliv. Rev, vol.99, pp.28-51, 2016.

N. Thomas, M. Pernot, R. Vanderesse, P. Becuwe, E. Kamarulzaman et al., Photodynamic therapy targeting neuropilin-1: interest of pseudopeptides with improved stability properties, Biochem. Pharmacol, vol.80, pp.226-235, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00470159

F. Thoreau, L. Vanwonterghem, M. Henry, J. L. Coll, and D. Boturyn, Design of RGD-ATWLPPR peptide conjugates for the dual targeting of alphaVbeta3 integrin and neuropilin-1, Org. Biomol. Chem, vol.16, pp.4101-4107, 2018.

J. D. Totten, T. Wongpinyochit, J. Carrola, I. F. Duarte, and F. P. Seib, PEGylationdependent metabolic rewiring of macrophages with silk fibroin nanoparticles, ACS Appl. Mater. Interfaces, vol.11, pp.14515-14525, 2019.

D. Tymecka, A. K. Puszko, P. F. Lipinski, B. Fedorczyk, B. Wilenska et al., Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: design, synthesis and biological activity, Eur. J. Med. Chem, vol.158, pp.453-462, 2018.

W. Xiao and H. Gao, The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system, Int. J. Pharm, vol.552, pp.328-339, 2018.

W. Xiao, J. Xiong, S. Zhang, Y. Xiong, H. Zhang et al., Influence of ligands property and particle size of gold nanoparticles on the protein adsorption and corresponding targeting ability, Int. J. Pharm, vol.538, pp.105-111, 2018.

S. Xu, B. Z. Olenyuk, C. T. Okamoto, and S. F. Hamm-alvarez, Targeting receptormediated endocytotic pathways with nanoparticles: rationale and advances, Adv. Drug Deliv. Rev, vol.65, pp.121-138, 2013.

Q. Yang, S. W. Jones, C. L. Parker, W. C. Zamboni, J. E. Bear et al., Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation, Mol. Pharm, vol.11, pp.1250-1258, 2014.

D. Zanuy, R. Kotla, R. Nussinov, T. Teesalu, K. N. Sugahara et al., Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor, J. Struct. Biol, vol.182, pp.78-86, 2013.

Q. Zhang and B. M. Reinhard, Ligand density and nanoparticle clustering cooperate in the multivalent amplification of epidermal growth factor receptor activation, ACS Nano, 2018.

H. Zhang, T. Wu, W. Yu, S. Ruan, Q. He et al., Ligand size and conformation affect the behavior of nanoparticles coated with in vitro and in vivo protein corona, ACS Appl. Mater. Interfaces, vol.10, pp.9094-9103, 2018.